When was SQZBiotech founded?

SQZBiotech was founded in 2013.

Where is SQZBiotech located?

SQZBiotech is headquartered in Boston, United States.

How many employees does SQZBiotech have?

As of Mar 01, 2026, the latest employee count at SQZBiotech is 50 - 199.

Is SQZBiotech a funded company?

SQZBiotech is a funded company, having raised a total of $168M across 17 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of SQZBiotech?

SQZBiotech's latest funding was a $***** Grant (prize money) round on Mar 21, 2022, with participation from 1 investor.

Where does SQZBiotech rank among its competitors?

SQZBiotech ranks 92nd amongst 3305 active competitors, of which 1129 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of SQZBiotech?

SQZBiotech's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Among them, Immuneel secured the most recent funding round in June, 2026.

SQZBiotech - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of cell therapies to treat multiple diseases. The company uses proprietary Cell Squeeze technology to deliver multiple biological materials into many cell types to engineer for therapeutic applications. The company has developed a pipeline for Oncology, Autoimmune and Infectious diseases.

Website: sqzbiotech.com
Social

Key Metrics

Founded Year

2013

Location

Boston, United States

Stage

Acquired

Total Funding

$168M in 17 rounds

Latest Funding Round

Grant (prize money), Mar 21, 2022, $*****

Investors

Polaris Partners & 27 more

Ranked

92^nd among 3305 active competitors

Employee Count

50 - 199 as on Mar 01, 2026

Similar Companies

Jazz Pharmaceuticals & 3029 more

Exit Details

Acquired by Stem Cell Technologies (Feb 29, 2024)

View SQZBiotech's full profile

SQZBiotech is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SQZ BIOTECHNOLOGIES CO CIN: 1604477 , United States, Active	Mar 21, 2013	$10M - $50M (As on Dec 31, 2022)	-	-
Sqz Biotechnologies Company CIN: 462431115 , United States, Active		-	1 (As on Dec 31, 2023)	-

SQZBiotech got acquired by Stem Cell Technologies on Feb 29, 2024.

Click here to take a look at SQZBiotech's acquisition in detail

SQZBiotech has raised a total funding of $168M over 17 rounds. Its latest funding round was a Grant (prize money) round on Mar 21, 2022 for $*****. 1 investor participated in its latest round. SQZBiotech has 28 institutional investors.

Here is the list of recent funding rounds of SQZBiotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2022	2300836	Grant (prize money)	1736870	3299327	6880419	1325764
Mar 14, 2022	9817637	Grant (prize money)	7695193	7641955	5295783	HHS
May 18, 2020	4414503	Series D	3948153	5090373	Temasek	Google Ventures & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of SQZBiotech's funding rounds and investors

The founders of SQZBiotech is Armon Sharei.

Here are the details of SQZBiotech's key team members:

Armon Sharei: CEO of SQZBiotech.
Contact Info: 1 email address

View details of SQZBiotech's Founder profiles and Board Members

SQZBiotech's employee count trend

SQZBiotech has 50 - 199 employees as of Mar 26. Here is SQZBiotech's employee count trend over the years:

Uncover SQZBiotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SQZBiotech include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Here is the list of Top 10 competitors of SQZBiotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 17 others	75/100
3rd	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, SV Health Investors & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Khosla Ventures & 23 others	71/100
92nd	SQZBiotech 2013, Boston (United States), Acquired	Developer of cell therapies to treat multiple diseases	$168M	Temasek, Invus & 26 others	63/100